Untitled Document
www.expresspharmaonline.com FORTNIGHTLY INSIGHT FOR PHARMA PROFESSIONALS
1-15 September 2007  
Untitled Document
Sections

Market
Management
Research
Pharma Life
Interphex IPA Convention Special

Services
Open Forum
Subscribe/Renew
Archives
Editorial Calendar
Media Kit
Contact Us
Network Sites
Express Computer
Network Magazine India
Express Channel Business
Express Hospitality
Express TravelWorld
feBusiness Traveller
Exp. Healthcare Mgmt.
Express Textile
Group Sites
ExpressIndia
Indian Express
Financial Express




    MARKET - The Business of Pharmaceuticals
 

Ring in the specialists
The growth of Indian pharma industry has catalysed the emergence of a parallel segment of service providers that caters to the needs of this industry. These service providers and their gamut of niche solutions have made their presence felt in the country. As their numbers shoot northwards, Nandini Patwardhan scans, to know more

GSK forays into the cardiovascular segment
GlaxoSmithKline has announced the launch of Carzec (carvedilol), a beta-blocker indicated in patients with heart failure and for the management of hypertension.

Torrent launches laxative in tablet form
Torrent Pharma has launched Fibotab (Calcium Polycarbophil) for the first time in India. Fibotab is a bulk laxative in a tablet form.

Allergan sets-up R&D center in Bangalore
California based Allergan has announced the opening of its new R&D center in Bangalore, its third largest outside the US.

Serum launches low-cost HIB vaccine
Serum Institute of India, announced the launch of its indigenously manufactured low-cost Haemophilus influenza type b conjugate vaccine under the brand name of "HibPRO" in India. HibPRO has been priced at MRP Rs 375 for a monodose vial.

MSD India launches Invanz
MSD India, a wholly owned subsidiary of US drug maker Merck & Co, has launched Invanz in India. Invanz is a broad-spectrum, injectable, carbapenem antibiotic developed and marketed by Merck.

Intas intensifies R&D efforts with focus on Europe
Leveraging on its European Union's GMP (EU-GMP) certification, Intas Bio- pharmaceuticals Limited (IBPL) will soon start clinical trials of its Filgrastim brand Neukine in Europe.

Ajanta licences technology to Taiwanese company
Ajanta Pharma has entered into an agreement to out-license the technology of its anti-scar product Vanizato Orient Europharma of Taiwan.

Arch Pharmalabs acquires Watsol Organics
Arch Pharmalabs has acquired Watsol Organics, a manufacturer of pharmaceuticals and agro-chemical intermediates in Hyderabad.

Strides buys fermentation facility in Italy
Strides has completed the acquisition of Diaspa, Italy; and has acquired its fermentation assets including its ongoing business in Milan.

Flamingo forays into Gujarat
Flamingo Pharmaceuticals has entered the Gujarat pharmaceuticals market. Flamingo launched a comprehensive range of innovative and quality formulations covering analgesics, antibiotics, anti-infectives, gastroenterologicals and orthocare in Ahmedabad and other cities of Gujarat.

Exploring homeopathy
Dr Batra's Positive Health Clinics recently announced interesting findings from an ACNeilson study on the growth prospects of the homeopathy market in India.

Events


Untitled Document
Untitled Document
© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.